Future of Digital Breast Tomosynthesis Market (2026-2033) | Breast Cancer Screening, Diagnostic Imaging, Women's Health |Major Players:- MaytronicsFujifilm, GE Healthcare, GMM (IMS Giotto)

DataM Intelligence has unveiled its latest report on the "Digital Breast Tomosynthesis Market Size 2026" delivering powerful insights into key trends, future growth opportunities, and evolving market challenges. Designed to empower smarter decision-making, the report equips businesses with the strategic intelligence needed to stay ahead in a competitive landscape. By blending robust qualitative analysis with data-driven quantitative research, DataM Intelligence offers a well-rounded perspective that helps organizations decode complex market dynamics, unlock new avenues for growth, and seize emerging opportunities in an ever-evolving global market.

Unlock Strategic Partnerships in the Growing Digital Breast Tomosynthesis Market-Connect with Key Industry Leaders Today: https://www.datamintelligence.com/partner-identification-enquiry/digital-breast-tomosynthesis-market?prtk

Global Digital Breast Tomosynthesis Market reached US$ 4.04 billion in 2025 and is expected to reach US$ 7.21 billion by 2033, growing at a CAGR of 7.5% during the forecast period 2026-2033

Digital Breast Tomosynthesis (DBT) is an advanced 3D mammography technique that improves breast cancer detection by providing clearer layered images. Market growth is driven by rising breast cancer incidence, increasing screening programs, technological advancements, and growing awareness about early diagnosis, leading to higher adoption in hospitals and diagnostic centers globally.

Download Free Sample Report (Get Higher Priority for Corporate Email ID):https://www.datamintelligence.com/download-sample/digital-breast-tomosynthesis-market?prtk

Recent Development United State-

✅ January 2026: Hologic Inc. expanded its 3D mammography (DBT) portfolio with enhanced AI-powered lesion detection software integrated into its Genius AI Detection platform, improving early breast cancer detection accuracy and workflow efficiency across U.S. diagnostic centers.

✅ November 2025: GE HealthCare introduced upgrades to its Senographe Pristina DBT system, incorporating advanced contrast-enhanced mammography and AI-driven image reconstruction to improve diagnostic confidence and reduce recall rates in breast screening programs.

✅ September 2025: Siemens Healthineers AG strengthened its U.S. breast imaging solutions by enhancing its MAMMOMAT Revelation platform with faster image acquisition and AI-based analytics, supporting high-throughput screening and precision diagnostics.

Recent Development Japan-

✅ February 2026: FUJIFILM Holdings Corporation advanced its AMULET Innovality DBT system in Japan by integrating next-generation image processing and AI-based diagnostic support, aimed at improving detection of dense breast tissues.

✅ December 2025: Canon Medical Systems Corporation expanded its breast imaging portfolio across Asia-Pacific with enhanced DBT capabilities in its mammography systems, focusing on low-dose imaging and improved patient comfort technologies.

✅ October 2025: Konica Minolta Inc. strengthened its digital radiography and breast imaging solutions by introducing AI-assisted diagnostic tools compatible with DBT workflows, supporting radiologists in early-stage cancer detection across Japan and regional markets.

Speak to Our Analyst and Get Customization in the report as per your requirements:https://www.datamintelligence.com/customize/digital-breast-tomosynthesis-market?prtk

List of the Key Players in the Digital Breast Tomosynthesis Market:
MaytronicsFujifilm,
GE Healthcare,
GMM (IMS Giotto)
Hologic, Inc.,
Planmeca (Planmed),
Siemens Healthineers,
Philips Healthcare,
AGFA Healthcare,
Trivitron Healthcare and
Carestream Health.

How Does Market Research Work in the Digital Breast Tomosynthesis Market?

Market research for the Digital Breast Tomosynthesis Market involves systematic data collection and analysis to understand industry trends, customer behavior, and competitive dynamics. It includes primary research such as surveys and interviews, and secondary research from reports, databases, and publications. Analysts evaluate market size, growth drivers, challenges, and opportunities using qualitative and quantitative methods. Insights are validated through expert opinions and forecasting models, enabling businesses to make strategic decisions, identify target segments, and gain a competitive advantage in a rapidly evolving market.

Latest Mergers and Acquisitions of Digital Breast Tomosynthesis Market:
✅ Siemens Healthineers & Onvida Health - Strategic "Value Partnership"
(April 2026)
Siemens Healthineers and Onvida Health signed a 10-year Value Partnership agreement to modernize the health system's diagnostic imaging fleet. This multi-year collaboration includes the deployment of Siemens' latest breast imaging technologies and long-term service arrangements to improve operational efficiencies and clinical outcomes in breast cancer screening.

✅ Blackstone & TPG Capital - Acquisition of Hologic, Inc.
(Closing Expected First Half 2026; Announced October 2025)
Private equity firms Blackstone and TPG Capital entered into a definitive agreement to acquire Hologic, Inc. in a transaction valued at approximately $18.3 billion. The deal provides Hologic, the pioneer in Digital Breast Tomosynthesis (Genius 3D Mammography), with massive capital resources to accelerate R&D and expand its global footprint in the women's health sector.

✅ ScreenPoint Medical & Ferrum Health - Strategic AI Governance Partnership
(January 2026)
ScreenPoint Medical and Ferrum Health partnered to offer the Transpara Breast AI solution through Ferrum's AI Governance Suite. This collaboration enables health systems to deploy validated AI for 3D mammography reading within a governed enterprise framework, ensuring quality and safety in automated cancer detection.

✅ Siemens Healthineers & NYU Langone Health - Strategic Imaging Partnership
(December 2025)
Siemens Healthineers entered into a $100 million, 5-year agreement with NYU Langone Health to provide equipment across its full imaging portfolio. This landmark partnership focuses on clinical firsts in AI and MRI, integrating Siemens' latest tomosynthesis systems into one of the leading academic medical centers in the United States.

Segments Covered in the Digital Breast Tomosynthesis Market 2026:

-By Product Type: 2D/3D Combination Systems Lead with Versatility
2D/3D combination systems dominate with an estimated 65% market share in 2024, as they provide both traditional full-field digital mammography and advanced tomosynthesis in a single platform, improving workflow efficiency and diagnostic accuracy.
Standalone 3D systems account for 35%, driven by facilities upgrading specifically to dedicated tomosynthesis capabilities for enhanced breast cancer detection.

-By Application: Screening Dominates with Preventive Focus
Screening applications hold around 60% share, supported by rising government initiatives and large-scale breast cancer screening programs emphasizing early detection.
Diagnostic applications represent 40%, used for detailed evaluation of suspicious findings, benefiting from higher-resolution 3D imaging.

Regional Analysis of the Digital Breast Tomosynthesis Market:

North America: 54.4% (Largest share, driven by strong U.S. dominance, advanced screening infrastructure, and high adoption of DBT systems).

Europe: 23% (Second largest, supported by government screening programs, aging population, and growing R&D investments). (Derived from multiple industry distributions as the next major contributor after North America)

Asia Pacific: 18% (Fastest growing, fueled by rising breast cancer incidence and expanding adoption in countries like Japan, China, and India).

Looking For Full Report? Get it Here:https://www.datamintelligence.com/buy-now-page?report=digital-breast-tomosynthesis-market?prtk

Key Benefits of the Report:

⏩ Comprehensive Market Insights: Gain a deep understanding of market size, trends, and structure.

⏩ Accurate Forecasting: Access reliable future projections to support long-term planning.

⏩ Competitive Analysis: Identify key players, strategies, and positioning in the market.

⏩ Data-Driven Decisions: Make informed business choices backed by verified data.

⏩ Opportunity Identification: Discover emerging trends and untapped growth areas.

⏩ Risk Mitigation: Reduce uncertainties with thorough market evaluation.

⏩ Customer Insights: Understand consumer behavior, preferences, and buying patterns.

⏩ Strategic Planning Support: Align business strategies with market realities.

⏩ Time & Cost Efficiency: Save resources by leveraging ready-to-use research.

⏩ Customization & Expert Validation: Benefit from tailored insights and industry expert analysis.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?prtk

People Also Ask:

◆ How big is the Digital Breast Tomosynthesis Market in 2025?
◆ What is the projected growth rate of the Digital Breast Tomosynthesis Market through 2033?
◆ Who are the key players in the Digital Breast Tomosynthesis Market?
◆ Which region is expected to dominate the industry during the forecast period?

Contact:
Fabian
DataM Intelligence 4market Research LLP
6th Floor, M2 Tech Hub, DataM Intelligence 4market Research LLP, Lalitha Nagar, Habsiguda, Secunderabad, Hyderabad, Telangana 500039
USA: +1 877-441-4866
UK: +44 161-870-5507
Email: fabian@datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.